AI will only bend the healthcare cost and outcomes curves when it stops living in pilots and starts operating as invisible infrastructure: quietly reducing fragmentation, extending care beyond the clinic, and aligning value for patients, employers, and plans. Mariano Garcia‑Valiño’s experience shows that real progress comes from solving chronic care economics, not from building clever tools in search of a buyer.
- Design AI around the realities of chronic disease: intermittent care, invisible symptoms, and massive gaps in patient education.
- Attack fragmentation first by creating continuous, low-friction touchpoints between patients, data, and clinicians.
- Align who decides, who pays, and who benefits—often by anchoring the business model with employers and their health plans.
- Use wearables as commodity sensors; treat data platforms and algorithms as the true strategic assets.
- Prototype fast, then insist on hard clinical and economic outcomes (event reduction, cost reduction) before scaling.
- Deploy AI agents as teammates—coding partner, meeting participant, creative assistant—while keeping humans in the loop for judgment and relationship.
- Push AI into your own day to win back time and reinvest it in upskilling, relationships, and getting outside the screen.
The Axenya Loop: A 6-Step System for Turning AI Into Clinical and Financial Gains
Step 1: Start From the Disease, Not the Data
Axenya began with a simple observation: our healthcare architecture was built to fight infectious disease, yet 85% of spending now goes to chronic conditions. That demands a different operating model. Instead of asking “What can we do with wearables?” Mariano asks, “What does diabetes, hypertension, or heart failure actually demand from patients and clinicians over the years?” The product flows from that clinical and behavioral reality, not from the novelty of the tech stack.
Step 2: Turn Intermittent Care Into Continuous Signals
Traditional care is episodic: a short office visit followed by six silent months. Chronic disease requires the opposite—constant, light-touch observation and timely nudges. Axenya’s early prototype simply pulled data from wearables into the cloud, monitored for risk patterns, and raised flags when patients appeared to need help. The sophistication grew, but the core principle remained: replace long stretches of clinical silence with continuous, intelligent listening.
Step 3: Use AI to Catch Mistakes Before They Become Events
Mariano points out that 50–60% of spending is tied to patient errors—misdosing, misunderstanding, or simply failing to notice that something is going wrong. AI becomes useful when it spots those invisible errors early enough to prevent a heart attack, aneurysm, or hospitalization. Axenya’s first deployments cut cardiac arrests, brain events, and mortality while also lowering cost—proof that the algorithms were catching the right things at the right time.
Step 4: Find the Economic Nexus Where All Stakeholders Win
The hardest part wasn’t the prototype; it was finding a place in the system where decision-maker, payer, and beneficiary line up. Direct-to-patient was too fragmented. Selling to individual clinicians was slow and scattered. Health plans alone struggled to align long-term incentives. The breakthrough was working with employers who purchase health plans: deploy digital tools across their covered population so patients feel better while employers see reduced healthcare spend. That alignment fuels scale.
Step 5: Treat Wearables as Commodities and Algorithms as the Moat
Axenya intentionally works with whatever devices people already use—Apple Health, Google Fit, Samsung, or dedicated medical sensors like Abbott FreeStyle Libre. Mariano’s view is clear: the enduring value isn’t the gadget, it’s the ability to ingest many sources, normalize them, and layer algorithms that keep getting better as lives and data accumulate. The flywheel is data → better models → better outcomes → more data; devices are simply on-ramps.
Step 6: Make AI a Team Member, Not a Headline
Inside Axenya, AI is woven into daily work: Claude helps with coding, understanding client context, and even joins meetings as an agent when Mariano can’t attend, generating a report he can query later. In his art, AI extends what’s possible with photography—upscaling, recomposing, and creatively modifying images—without becoming the point of the work. That’s the lesson for leaders: when AI becomes an invisible collaborator instead of a marketing slogan, it starts compounding value.
Where Chronic Care Models Break — And How Axenya Rebuilds Them
Dimension | Old Infectious-Disease Model | Unsolved Chronic Disease Reality | Axenya-Inspired AI-Enabled Approach |
|---|---|---|---|
Patient Journey | Short, symptom-driven episodes; clear start and finish to treatment. | Long, often lifelong condition with few obvious symptoms until it’s too late. | Continuous monitoring and education, with AI surfacing when intervention is needed. |
Clinician Role | Wait for the patient to present; prescribe a simple, time-bound regimen. | Expected to transfer 10x more knowledge and behavior change in the same brief visit. | Extend clinician reach with data-driven alerts and structured insights between visits. |
Economics & Buyer | Systems built around acute episodes and short-term payments. | Costs grow 2.5x inflation; payers and patients juggle rising chronic-care bills. | Anchor around employers and health plans where savings and health gains accrue together. |
Leadership Takeaways: Questions to Pressure-Test Your AI Healthcare Strategy
Are we designing our AI features around specific chronic disease behaviors, or just layering tech onto existing workflows?
If your product doesn’t explicitly solve for the invisibility of symptoms, adherence complexity, and the need for ongoing patient education, you’re still in “feature” territory. Follow Mariano’s lead and start from the disease mechanics first, then back to what AI needs to do every day for patients and clinicians.
Where, concretely, do decision-maker, payer, and beneficiary align in our go-to-market motion?
Map your stakeholders the way Axenya did: patients, clinicians, health plans, and employers. If you don’t have a segment where one party both pays and clearly captures savings, adoption will stall. Employers attached to group health plans are often the most practical starting point for chronic care solutions.
Are we treating devices as the product instead of treating data and algorithms as the core asset?
If device integrations and hardware features dominate your roadmap, you’re likely over-investing in what will be commoditized. Shift the center of gravity toward scalable data ingestion, normalization, and model performance that can ride on any mainstream wearable platform.
Do we have evidence that our AI actually reduces clinical events and cost, or only that users “engage” with it?
Engagement is a weak proxy in healthcare. Follow Axenya’s pattern: track hard outcomes such as reductions in cardiac events, aneurysms, and mortality, as well as total cost. Use small, well-instrumented cohorts (like Mariano’s initial 150,000 lives) to prove impact before expanding coverage.
Inside our own organization, is AI a daily teammate or still a novelty?
Look at how your teams work. Are engineers pairing with an LLM to write and review code? Are agents attending meetings and producing digestible summaries? Are creatives using AI to expand what’s possible in their craft? The more routine and invisible these patterns become, the more leverage you’re actually getting from AI.
Author: Emanuel Rose, Senior Marketing Executive, Strategic eMarketing
Contact: https://www.linkedin.com/in/b2b-leadgeneration/
Last updated:
- Conversation with Mariano Garcia‑Valiño on “Marketing in the Age of AI” (episode transcript provided by the host).
- Axenya company recognition as one of Newsweek’s World’s Best Digital Health Companies (as noted in guest materials).
- Mariano Garcia‑Valiño’s professional background: engineering degree (University of Buenos Aires), Harvard MBA, Fulbright Scholar (from guest notes).
- Operational metrics and impact examples cited directly from Mariano’s description of Axenya deployments in the interview.
About Strategic eMarketing: Strategic eMarketing helps growth-minded organizations turn clear positioning, authentic storytelling, and AI-enabled systems into measurable revenue and stronger customer relationships.
https://strategicemarketing.com/about
https://www.linkedin.com/company/strategic-emarketing
https://podcasts.apple.com/us/podcast/marketing-in-the-age-of-ai-with-emanuel-rose/id1741982484
https://open.spotify.com/show/2PC6zFnFpRVismFotbNoOo
https://www.youtube.com/channel/UCaLAGQ5Y_OsaouGucY_dK3w
Guest Spotlight
Guest: Mariano Garcia‑Valiño
LinkedIn: https://www.linkedin.com/in/mgarciavalino/
Company: Axenya (recognized by Newsweek as one of the World’s Best Digital Health Companies)
Episode: Marketing in the Age of AI with Emanuel Rose — conversation on building and scaling AI‑enabled healthcare that bridges advanced medical science and patients’ daily lives.
Contact: m@axenya.com
About the Host
Emanuel Rose is a senior marketing executive and founder of Strategic eMarketing, helping companies implement authentic, AI-supported marketing systems that generate real business outcomes. Connect with him on LinkedIn: https://www.linkedin.com/in/b2b-leadgeneration/.
From Insight to Action: What You Can Do This Week
Audit one chronic-care initiative or product line and ask the three Axenya-inspired questions: Are we continuous, are we catching mistakes early, and is our buyer aligned with the value? Then pick a single workflow inside your team—coding, meetings, or reporting—and deliberately add an AI “teammate” for 30 days, measuring how much time and clarity you gain to reinvest in deeper work and human connection.